VBWG
Monograph

Vascular Biology in Clinical Practice © Vol. 4, No. 2

• Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression

This monograph, Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression, is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine. Coeditors are Carl J. Pepine, MD and William Parmley, MD.

Beta-blockers have been evaluated in more than 10,000 patients with stable heart failure in long-term placebo-controlled clinical trials. This monograph highlights several new studies that have examined the safety and efficacy of beta-blockers in new subgroups of patients. The results should accelerate the use of beta-blockade in a wider range of patients with heart failure to lower their risk of morbidity and mortality. The monograph also discusses the scientific rationale for beta-blockade in heart failure.




CME_Monograph.pdf (0.6MB)CME_Monograph.pdf (0.6MB)


biologycontinuingEducationFloridaimperativemonographprogramsProgressionvascularVol

Related at vwbg.org

Vascular Biology in Clinical Practice © Vol. 4, No. 5

The potential role of beta-blockade in blunting the progression of atherosclerosis

This monograph, The potential role of beta-blockade in blunting the progression of atherosclerosis , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 5, No. 3

Atrial fibrillation and thromboembolism: Implications for stroke prevention

This monograph, Atrial fibrillation and thromboembolism: Implications for stroke prevention , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 5, No. 2

Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials

This monograph, Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.
More related